The critical challenges to the British NHS are the consequences of us all living longer having to manage chronic conditions over time expecting and demanding more and being denied many innovative new drugs notably for cancer which cannot be afforded at present by the too narrowly funded NHS. This needs to be changed in line with more successful funding systems in Europe Australia and the Far East where outcomes are much better than in the UK. This radical new book offers economic solutions based